Dr. Yair Schindel, M.D.

Co-Founder and Managing Partner

Yair Schindel
Yair Schindel

About Yair

Yair is the Managing Partner and co-founder of aMoon.

Previously, Yair served as the founding CEO of the State of Israel’s National Digital Bureau, responsible for digitizing governmental services and stimulating economic growth.

Yair is the founder of the MAOZ Network, an NGO building collaboration between Israel’s most influential leaders, with over 300 alumni dedicated to building collaboration between the private, social and public sectors.

Yair was an executive, investor, board or advisory board member in several healthcare startups including OmniGuide, Zebra Medical Vision, and Medisafe.

Yair earned his BSc and MD degrees at Ben-Gurion University and his MBA at Harvard Business School. He served in the IDF for five years and graduated as Chief Medical Officer for the Israeli Navy Seals, known as “Shayetet 13”.


aMoon invests in $80m Adicet Bio financing round

October 3, 2019

Based on technology developed by the Technion’s Prof. Yoram Reiter, Adicet Bio is developing allogeneic cell therapies for cancer using innovative gamma delta T cells.

Read More

Israel’s Zebra Medical gets FDA ok for AI chest X-ray product

May 13, 2019

Zebra Medical Vision said on Monday it received approval from the U.S. Food and Drug Administration for its artificial intelligence-based chest X-ray triage product.

Read More

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION

August 2, 2018

Advances Phase 2 Study in Alzheimer’s Disease in Canada, RPh201 development in US supported by Fast Track Designation by US Food and Drug Administration

Read More

Israeli firm creates particles to kill germs on contact, fight bacterial disease

August 2, 2018

With product initially aimed for dental industry, Petah-Tikva based Nobio raises $3.6 million from aMoon Fund and Dr. Ole Jensen, a US surgeon and dentist

Read More

Zebra Medical Vision gets $30M Series C to create AI-based tools for radiologists

June 7, 2018

Zebra Medical Vision, an Israeli medical imaging startup that uses machine and deep learning to build tools for radiologists, has raised a $30 million Series C led by health technology…

Read More

Marius Nacht to invest $20m in Regenera

January 2, 2018

aMoon Partners, controlled and managed by by Check Point Software Technologies Ltd. (Nasdaq: CHKP) cofounder Marius Nacht, together with Dr. Yair Schindel, is likely to invest $20 million more in pharma company Regenera,…

Read More

Nacht, Harel Insurance invest in personalized cancer treatment

December 7, 2017

Ayala Pharmaceuticals has bought rights from international company Bristol-Myers Squibb (BMS) to develop a personalized treatment for cancer. Ayala, founded a few months ago for this purpose, is an initiative…

Read More

Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments

December 6, 2017

REHOVOT, Israel–(BUSINESS WIRE)–Ayala Pharmaceuticals, a biopharmaceutical company dedicated to developing targeted cancer therapies, announced today that they have entered into an exclusive worldwide license agreement with Bristol-Myers Squibb for two…

Read More

Mapi Pharma Ltd. Announces Closing of $10 Million Investment

August 17, 2017

Mapi Pharma Ltd., a privately held, fully integrated, clinical stage biopharmaceutical company has completed an investment round of $10 million by aMoon Fund. aMoon Fund is an Israeli investment firm focused on innovative Israeli healthcare and life science…

Read More

Israeli Universal Flu Vaccine Maker Receives $2.8 Million Investment

January 4, 2017

Israeli billionaire Marius Nacht is banking on Israeli bio-tech with a $2.8 million investment into BiondVax Pharmaceuticals, a clinical phase company developing a universal flu vaccine.

Read More